- call +1-201-465-4211
- email sales@mrinsights.biz
Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.
Scope of the Report:
This report focuses on the Anti-Suicide Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Anti-Suicide Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 4610 million US$ in 2023, from 3600 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Pfizer
AstraZeneca plc
Eli Lilly and Company
Allergan plc
GlaxoSmithKline plc
Merck & Co., Inc
H. Lundbeck A/S
NeuroRx, Inc
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-Depressants and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Market Segment by Applications, can be divided into
Hospitals
Retail pharmacies
Online pharmacies
There are 15 Chapters to deeply display the global Anti-Suicide Drugs market.
Chapter 1, to describe Anti-Suicide Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Suicide Drugs, with sales, revenue, and price of Anti-Suicide Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Suicide Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Suicide Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Suicide Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Suicide Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Anti-Depressants and Anti-Anxiety Drugs
1.2.2 Anti-Psychotic Drugs
1.2.3 NMDA Antagonist
1.2.4 Antibiotic Analog
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Retail pharmacies
1.3.3 Online pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Anti-Suicide Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca plc
2.2.1 Business Overview
2.2.2 Anti-Suicide Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca plc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly and Company
2.3.1 Business Overview
2.3.2 Anti-Suicide Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Company Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan plc
2.4.1 Business Overview
2.4.2 Anti-Suicide Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan plc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline plc
2.5.1 Business Overview
2.5.2 Anti-Suicide Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline plc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck & Co., Inc
2.6.1 Business Overview
2.6.2 Anti-Suicide Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck & Co., Inc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 H. Lundbeck A/S
2.7.1 Business Overview
2.7.2 Anti-Suicide Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 H. Lundbeck A/S Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 NeuroRx, Inc
2.8.1 Business Overview
2.8.2 Anti-Suicide Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 NeuroRx, Inc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.2 Anti-Suicide Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Johnson & Johnson Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Suicide Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Suicide Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Suicide Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Suicide Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Suicide Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Suicide Drugs Market Analysis by Regions
4.1 Global Anti-Suicide Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Suicide Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Suicide Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
4.5 South America Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
5 North America Anti-Suicide Drugs by Countries
5.1 North America Anti-Suicide Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
6 Europe Anti-Suicide Drugs by Countries
6.1 Europe Anti-Suicide Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
6.3 UK Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
6.4 France Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Suicide Drugs by Countries
7.1 Asia-Pacific Anti-Suicide Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
7.5 India Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
8 South America Anti-Suicide Drugs by Countries
8.1 South America Anti-Suicide Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Suicide Drugs by Countries
9.1 Middle East and Africa Anti-Suicide Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Suicide Drugs Sales and Growth Rate (2013-2018)
10 Global Anti-Suicide Drugs Market Segment by Type
10.1 Global Anti-Suicide Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Suicide Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Suicide Drugs Revenue and Market Share by Type (2013-2018)
10.2 Anti-Depressants and Anti-Anxiety Drugs Sales Growth and Price
10.2.1 Global Anti-Depressants and Anti-Anxiety Drugs Sales Growth (2013-2018)
10.2.2 Global Anti-Depressants and Anti-Anxiety Drugs Price (2013-2018)
10.3 Anti-Psychotic Drugs Sales Growth and Price
10.3.1 Global Anti-Psychotic Drugs Sales Growth (2013-2018)
10.3.2 Global Anti-Psychotic Drugs Price (2013-2018)
10.4 NMDA Antagonist Sales Growth and Price
10.4.1 Global NMDA Antagonist Sales Growth (2013-2018)
10.4.2 Global NMDA Antagonist Price (2013-2018)
10.5 Antibiotic Analog Sales Growth and Price
10.5.1 Global Antibiotic Analog Sales Growth (2013-2018)
10.5.2 Global Antibiotic Analog Price (2013-2018)
11 Global Anti-Suicide Drugs Market Segment by Application
11.1 Global Anti-Suicide Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Retail pharmacies Sales Growth (2013-2018)
11.4 Online pharmacies Sales Growth (2013-2018)
12 Anti-Suicide Drugs Market Forecast (2018-2023)
12.1 Global Anti-Suicide Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Suicide Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Suicide Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-Suicide Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Suicide Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-Suicide Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Suicide Drugs Market Forecast (2018-2023)
12.3 Anti-Suicide Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Suicide Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Suicide Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-Suicide Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Suicide Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Suicide Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Suicide Drugs Picture
Table Product Specifications of Anti-Suicide Drugs
Figure Global Sales Market Share of Anti-Suicide Drugs by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
